← Back to guidelines
Neurology18 papers

Neuralgic amyotrophy

Last edited: 4/15/2026

Overview

Neuralgic amyotrophy, also known as brachial neuritis, is characterized by acute pain followed by muscle weakness and atrophy, primarily affecting the shoulder and upper extremity. It can present in hereditary and sporadic forms with varying clinical courses 1.

Diagnosis

  • Clinical Presentation: Acute onset of severe pain in the shoulder and upper arm, followed by muscle weakness and atrophy, often asymmetric 13.
  • Electrophysiological Studies: Nerve conduction studies may show denervation patterns supporting the diagnosis 1.
  • Differential Diagnosis: Exclude other causes of brachial plexus lesions, including trauma, tumors, and inflammatory conditions 1.
  • Management

  • Symptomatic Treatment: Analgesics (e.g., NSAIDs) and corticosteroids for pain management 1.
  • Physical Therapy: Early mobilization and rehabilitation to prevent contractures and improve function 1.
  • Occasional Use of Immunosuppressive Therapy: In severe cases, consideration of immunosuppressive agents like IVIG or corticosteroids, though evidence is limited 1.
  • Special Populations

  • Diabetes: Patients with diabetes may experience neuralgic amyotrophy, suggesting a possible link between metabolic factors and disease onset 2.
  • Familial Cases: Hereditary forms can occur within families, with potential genetic heterogeneity affecting clinical course 13.
  • Key Recommendations

  • Recognize two distinct clinical courses of hereditary neuralgic amyotrophy: relapsing-remitting and chronic undulating, guiding long-term prognosis and management strategies (Evidence: Moderate 1).
  • Consider genetic heterogeneity in hereditary cases, as evidenced by linkage analysis findings, for genetic counseling and family screening (Evidence: Moderate 1).
  • Monitor and manage residual symptoms aggressively due to persistent functional impairment, often indicated by a median Rankin score of 2 (Evidence: Moderate 1).
  • Investigate potential associations between diabetes and neuralgic amyotrophy to inform risk assessment and management in diabetic patients (Evidence: Weak 2).
  • References

    1 van Alfen N, van Engelen BG, Reinders JW, Kremer H, Gabreëls FJ. The natural history of hereditary neuralgic amyotrophy in the Dutch population: two distinct types?. Brain : a journal of neurology 2000. link 2 Williams AJ. Diabetic neuralgic amyotrophy. Postgraduate medical journal 1981. link 3 Martinelli P, Pazzaglia P, Marchiori L, Lugaresi E. Simultaneous occurrence of neuralgic amyotrophy in three members of one family. European neurology 1980. link

    Original source

    1. [1]
      The natural history of hereditary neuralgic amyotrophy in the Dutch population: two distinct types?van Alfen N, van Engelen BG, Reinders JW, Kremer H, Gabreëls FJ Brain : a journal of neurology (2000)
    2. [2]
      Diabetic neuralgic amyotrophy.Williams AJ Postgraduate medical journal (1981)
    3. [3]
      Simultaneous occurrence of neuralgic amyotrophy in three members of one family.Martinelli P, Pazzaglia P, Marchiori L, Lugaresi E European neurology (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG